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Loss-less Nano-fractionator for High
Sensitivity, High Coverage Proteomics*□S
Nils A. Kulak‡§¶, Philipp E. Geyer‡¶, and Matthias Mann‡**
Recent advances in mass spectrometry (MS)-based pro-
teomics now allow very deep coverage of cellular pro-
teomes. To achieve near-comprehensive identification
and quantification, the combination of a first HPLC-based
peptide fractionation orthogonal to the on-line LC-MS/MS
step has proven to be particularly powerful. This first
dimension is typically performed with milliliter/min flow
and relatively large column inner diameters, which allow
efficient pre-fractionation but typically require peptide
amounts in the milligram range. Here, we describe a novel
approach termed “spider fractionator” in which the post-
column flow of a nanobore chromatography system en-
ters an eight-port flow-selector rotor valve. The valve
switches the flow into different flow channels at constant
time intervals, such as every 90 s. Each flow channel
collects the fractions into autosampler vials of the LC-
MS/MS system. Employing a freely configurable collec-
tion mechanism, samples are concatenated in a loss-less
manner into 2–96 fractions, with efficient peak separation.
The combination of eight fractions with 100 min gradients
yields very deep coverage at reasonable measurement
time, and other parameters can be chosen for even more
rapid or for extremely deep measurements. We de-
monstrate excellent sensitivity by decreasing sample
amounts from 100 g into the sub-microgram range,
without losses attributable to the spider fractionator and
while quantifying close to 10,000 proteins. Finally, we
apply the system to the rapid automated and in-depth
characterization of 12 different human cell lines to a
median depth of 11,472 different proteins, which re-
vealed differences recapitulating their developmental
origin and differentiation status. The fractionation tech-
nology described here is flexible, easy to use, and facil-
itates comprehensive proteome characterization with
minimal sample requirements. Molecular & Cellular
Proteomics 16: 10.1074/mcp.O116.065136, 694–705,
2017.
Mass spectrometry (MS)-based bottom-up proteomic work-
flows consist of multiple steps, namely sample preparation,
on-line liquid chromatography (LC) coupled with MS meas-
urements, followed by computational data analysis, and in-
terpretation. LC-MS/MS technologies have improved drasti-
cally from the initial identification of one or a few proteins
using manual, complex, and time-consuming protocols to
essentially complete proteomic coverage of microorganisms
in a rapid and streamlined manner (1–4). These advances are
based on multiple breakthroughs in the analytical and com-
putational sides of the proteomic workflow over the last dec-
ade and nowmake MS-based proteomics a powerful player in
systems biology (5). However, for complex proteomes, such
as human cell lines, organs, and body fluids, very deep char-
acterization still involves great effort, sample amounts, and
costs. Therefore, there is a continuing need for more pow-
erful workflows, and here we contribute to these efforts in
the important area of peptide pre-separation before the
LC-MS/MS analysis.
To yield in-depth proteomes of complex biological samples,
two-dimensional separation approaches at the peptide level
are attractive because they are more universally applicable
than protein level fractionation. First dimension separation
techniques range from isoelectric focusing (6–9) and pipette-
based approaches such as StageTip fractionation (10–12) to
off-line HPLC systems (13–17). High pH reversed-phase frac-
tionation, alternatively termed basic reversed-phase, as a first
off-line chromatography separation in combination with the
low pH reversed-phase fractionation in the second on-line
dimension was first demonstrated more than 10 years ago. In
comparison with other methodologies, it benefits from the
uniform first dimensional peptide elution profiles achievable
with high pH reversed-phase separation and the high pep-
tide separation efficiency in both dimensions (18, 19). Be-
cause the two separation dimensions are not completely
orthogonal (meaning that peptide retention times are still cor-
related), direct application of high pH fractionation would lead
to non-uniform filling of the gradient in the second dimension.
The key advance that solved this problem was the combina-
tion of fractions that elute at substantially different times in the
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first dimension (13). This “concatenation” tends to uniformly
fill the gradients, leading to deeper proteomes independent of
the nature of the sample, while maintaining throughput (20–
22). This two-dimensional separation technique, combining
high pH fractionation with concatenation, compares favorably
with other approaches and is increasingly being applied by
the proteomics community (20, 23–27).
Despite the success of high pH reversed-phase fraction-
ation in the deep characterization of complex proteomic sam-
ples, a current limitation is the requirement for rather large
amounts of starting material. This is due to the large column
diameters, flow rates, and number of fractions that are col-
lected before concatenation to preserve peak separation from
the first dimension and to maintain collection volumes that
can easily be handled. Therefore, instead of the nanoflow
systems typical of on-line separation, much larger columns
and flow rates are almost always employed. This in turn
requires large sample sizes, and milligram amounts of starting
material are typical for high pH reversed-phase fractionation.
Unfortunately, this implies high reagent costs, for instance for
proteolytic enzymes or for the chemical labeling reagents
used in multiplexing. Furthermore, it restricts deep proteomes
preliminary to cases where comparatively large protein
amounts are available and excludes the investigation of rare
cellular subpopulation or laser micro-dissected cells in tumor
tissues, for instance. High pH fractionation with higher flow
rates and larger sample amounts is also used to investigate
post-translational modifications in great depth by the combi-
nation of isobaric mass tag labeling of peptides after diges-
tion, followed by high pH fractionation and consecutive en-
richments (28). In such cases, large sample amounts and high
volumes are necessary because of the subsequent enrich-
ment. However, post-translational modification analysis could
benefit from a drastic scale-down in high pH fractionation, if
already enriched peptides are fractionated. This would neces-
sitate high sensitivity of the fractionation step and be eco-
nomically attractive in terms of labeling reagents.
Here, we describe a novel approach that allows efficient
sample concatenation without using large volumes. Instead,
nanoflow systems are employed, and the intermediate sample
collection step is eliminated. We demonstrate the operating
principle of our spider fractionator, show that fractionation
efficiency remains very high, and establish that the flexibility
of the system allows choosing an optimum balance between
measurement time and desired depth of proteome coverage.
Very low sample amounts can be separated without apparent
fractionation-induced sample losses. We demonstrate the
sensitivity of the system by the analysis of 12 human cell lines
to a depth of about 10,000 proteins with only 1 g of sample.
MATERIALS AND METHODS
Cell Culture—HeLa cells were cultured in high glucose DMEM with
10% fetal bovine serum and 1% penicillin/streptomycin (all from Life
Technologies, Inc.). Cell lines were cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) containing 10% dialyzed fetal bovine
serum and penicillin/streptomycin. Cells were counted using a count-
ess cell counter (Invitrogen), and aliquots of 106 cells were snap-
frozen and stored at 80 °C.
Tryptophan Fluorescence Emission Assay for Protein Quantifica-
tion—Protein concentrations were determined after solubilizing the
samples in 8 M urea by tryptophan fluorescence emission at 350 nm
using an excitation wavelength of 295 nm. Tryptophan at a concen-
tration of 0.1 g/l in 8 M urea was used to establish a standard
calibration curve (0–4 l). From this, we estimated that 0.1 g/l
tryptophan are equivalent to the emission of 7 g/l of human protein
extract, assuming that tryptophan on average accounts for 1.3% of
human protein amino acid composition.
Sample Preparation, Protein Digestion, and in-StageTip Purifica-
tion—Sample preparation was performed as described previously (3)
with the following adaptations. 300 g of cells were suspended in 50
l of SDC reduction and alkylation buffer (3). We used 2-chloro-N,N-
diethylacetamide as alkylating reagent for the comparison of the 13
cell lines and 2-chloro-acetamide for all other experiments. The cells
were kept at 95 °C for 5 min to denature proteins and afterward
sonicated to shear DNA and enhance cell disruption with a water bath
sonicator (Bioruptor, model UCD-200, Diagenode) for 15 min at the
maximum level. The proteolytic enzymes LysC and trypsin were
added in a 1:100 ratio (micrograms of enzyme to micrograms of
protein), and the solution was incubated for 4 h at 37 °C.
Peptides were acidified by adding 100 l of ethyl acetate, 1% TFA
and extensive mixing for 2 min, and 20 g were transferred into
StageTips containing two 14-gauge SDB-RPS (poly(styrene-divinyl-
benzene) reversed phase sulfonate) plugs. Afterward, the StageTips
were washed with 100 l of ethyl acetate, 1% TFA to strip SDC and
lipids from the digested cells. This was followed by a wash step with
100 l of ddH2O
1, 0.2% TFA. The purified peptides were eluted with
60 l of 80% acetonitrile, 19% ddH2O, 1% ammonia in autosampler
vials. For all steps, the StageTips were centrifuged at 2,000  g until
the solutions were rinsed through completely. The collected material
was dried using a SpeedVac centrifuge at 60 °C (Eppendorf, Concen-
trator Plus). Peptides were suspended in 2% acetonitrile, 0.1% TFA in
ddH2O and sonicated for 15 min in a water bath sonicator (Branson
Ultrasonics, Ultrasonic Cleaner Model 2510). Moreover, 6,600 HeLa
cells, the equivalent to 1 g of starting material (29), were separately
digested using the in-StageTip protocol (3) with the above mentioned
adaptations.
Pre-fractionation—We constructed a software-controlled, fully au-
tomated, rotor-valve-based fraction collector system coupled on line
to a nanoflow HPLC (EASY-nLC 1000 system, Thermo Fisher Scien-
tific), and we used this for all high pH reversed-phase pre-fraction-
ations. The fraction collector system was named Spider Fractionator
and is under commercial development by PreOmics GmbH, Martin-
sried, Germany. We provide a list of components used in constructing
the fractionator (supplemental Table 1). For the work reported here,
we standardized on a first dimension column of 250 m inner diam-
eter and a length of 30 cm, which was packed with 1.9 m C18
particles (ReproSil-Pur C18-AQ 1.9 m resin by Dr. Maisch GmbH)
and has an estimated loading capacity of at least 100 g. The column
is available from PreOmics GmbH (Article No. P.O. 00007). All col-
umns (first dimension and on-line dimension) were passivated by a
single run of BSA to saturate irreversible binding sites. For separation
into eight pooled fractions, we loaded 20 g (or other amounts where
indicated) of purified and digested peptides onto a reversed-phase
C18 column. A gradient was generated by using a dual buffer system
(buffers A and B) also from PreOmics GmbH (Article No. P.O. 00009).
1 The abbreviations used are: ddH2O, double distilled H2O; SMC,
smooth muscle cell; EC, embryonic carcinoma.
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Peptides were eluted from 3% B to 30% B in 45 min followed by a
linear increase to 60% B in 17 min. This gradient was followed by a
further linear increase to 95% B in 5 min and a 3 min wash at 95% B,
followed by a 10 min decrease to 3% B. The last segments ensure
that the output lines (volume about 800 nl) are emptied, and none of
the remaining peptides are lost. The flow rate was kept at a con-
stant 2 l/min. The 96-well plate was moved by a stepper motor-
driven linear actuator. Software was implemented on a Raspberry
microcontroller.
We separated peptides into 4, 8, 16, and 24 fractions using rotor
valve shifts of 90 s. Fractions were collected into 0.2-ml thin-walled
8-tube strips (Thermo Fisher Scientific). We loaded 20 g of starting
material for 4 and 8 fractions, 40 g for 16 fractions, and 60 g for 24
fractions.
The concatenation scheme of table I was used for pooling. For a
more detailed version of the fractionation schemes see supplemental
Fig. 1.
The pooled fractions were dried using a SpeedVac centrifuge at
60 °C (Eppendorf, Concentrator Plus). Peptides were suspended in
2% acetonitrile, 0.1% TFA in ddH2O and sonicated for 15 min in a
water bath sonicator (Branson Ultrasonics, Ultrasonic Cleaner Model
2510). A total of 2 g of each concatenated fraction was loaded and
measured by LC-MS/MS as described below.
Comparison of the Spider Fractionator to Other High pH Fraction-
ation Systems—We used the same buffers, gradients, and pooling
scheme as for the spider fractionator system in comparison with a
higher flow system and to a recently introduced spin column system.
For all three systems, the same HeLa digest was used to fractionate
1 or 20 g of peptides. The higher flow system consisted of an
XBridge peptide BEH C18 column (2.5 m particle size, 2.1  250
mm, Waters) with a Shimadzu HPLC system at a 60 °C run at a flow
rate of 150 l/min. The fractions were manually pooled. For the 1 g
sample, all fractions were re-pooled into a single vial to determine
sample loss. For the 20 g sample, we manually concatenated sam-
ples according to the same scheme as automatically done by the
spider fractionator. On the spin system (high pH reversed-phase
peptide fractionation kit, Pierce catalog number 84868), separation
was done according to the manufacturer’s instructions resulting in
eight fractions but no concatenation.
Ultra-high Pressure Liquid Chromatography and Mass Spectrome-
try—Samples were measured using LC-MS instrumentation consist-
ing of an EASY-nLC 1000 ultra-high pressure system (Thermo Fisher
Scientific) coupled via a nanoelectrospray ion source (Thermo Fisher
Scientific) to a hybrid quadrupole Orbitrap mass spectrometer (Q
Exactive HF Orbitrap from Thermo Fisher Scientific) (30, 31). Purified
peptides were separated on 40 cm HPLC columns (75 m inner
diameter; in-house packed into the tip) at 60 °C with ReproSil-Pur
C18-AQ 1.9 m resin by Dr. Maisch GmbH).
For all measurements, peptides were loaded in buffer A (0.1%
formic acid, 5% DMSO (32)) and eluted with a linear 55 min gradient
of 2–20% of buffer B (0.1% formic acid, 5% DMSO, 80% acetonitrile),
followed by an increase to 40% buffer B within 40 min and afterward
within 2 min to 98% buffer B and a 2 min wash at 98% buffer B. The
flow rate was kept at 350 nl/min.
Column temperature was kept at 60 °C by an in-house-developed
oven containing a Peltier element, and parameters were monitored in
real time by the SprayQC software (33).
MS data was acquired with the Thermo Xcalibur software version
3.0.63, a topN method where N could be up to 100. This method in
principle allows a very large number of precursor peaks to be picked
for fragmentation but is in practice limited by the number of precur-
sors with sufficient ion intensity. In the entire data set, N was 15 on
average. Target values for the full scan MS spectra were 3  106
charges in the 300–1,650m/z range with a maximum injection time of
15 ms. Transient times corresponding to a resolution of 60,000 atm/z
200 were chosen. A 1.5m/z isolation window and a fixed first mass of
100 m/z were used for MS/MS scans. Fragmentation of precursor
ions was performed by higher energy C-trap dissociation (34) with a
normalized collision energy of 27 eV. MS/MS scans were performed
at a resolution of 15,000 atm/z 200 with an ion target value of 5 104
and a maximum injection time of 25 ms. Dynamic exclusion was set
to 30 s to avoid repeated sequencing of identical peptides.
Data Analysis—MS raw data files were analyzed by MaxQuant
software version 1.5.3.31 (35), and peptide lists were searched by the
Andromeda search engine (36) against the human Uniprot FASTA
database to which common contaminant proteins had been added
(86,746 entries) with cysteine diethylcarbamidomethylation as a fixed
modification for the comparison of the 13 cell lines and cysteine
carbamidomethylation as a fixed modification for all other experi-
ments. N-terminal acetylation and methionine oxidations were used
as variable modifications in all experiments. The false discovery rate
was set to 0.01 for both proteins and peptides with a minimum length
of 7 amino acids and was determined by searching a reverse data-
base. Enzyme specificity was set to trypsin and a maximum of two
missed cleavages were allowed in the database search. Peptide
identification were performed with an allowed initial precursor mass
deviation up to 7 ppm and an allowed fragment mass deviation of 20
ppm. The MaxQuant feature “match between runs” was enabled
within the dataset of the pooled eight fractions and the single shot
samples for all cell line samples. Proteins matching the reversed
database were filtered out. Label-free protein quantification was done
with a minimum ratio count of 1 (37). All bioinformatics analyses were
performed within the Perseus software of the MaxQuant computa-
tional platform (35, 37).
RESULTS
Spider Fractionator—The principle of the fractionator is de-
picted in Fig. 1. The post-column flow from the first dimension
separation enters the input port of an eight-port flow-selector
rotor valve. At pre-determined time intervals, the valve
switches to a new output port. Each of the outputs is con-
nected via a narrow bore capillary to different output lines in a
sample collection device, distributing the sample flow into
consecutive tubes for the pooled fractions. Once one cycle
has been completed, the valves switches back to the first
output port and the next fluid volume is added to the already
TABLE I
Concatenation scheme
No. pooled fractions 4 8 16 24
Peptide amount (g) 20 20 40 60
No. of non-pooled fractions 54 54 54 54
Pooling scheme 1;5;9;13;17;21;25;29;33;37;41;45;49;53 1;9;17;25;33;41;49 1;17;33;49 1;25;49
2;6;10;14;18;22;26;30;34;38;42;46;50;54; etc. 2;10;18;26;34;42;50; etc. 2;18;34;50; etc. 2;26;50; etc.
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collected first fraction. In this way, the device automatically
concatenates and pools the samples, without requiring differ-
ent collection tubes or the combination of separately col-
lected effluent volumes. Therefore, the volumes are not con-
strained to a minimum size, which would otherwise be
necessary to handle them in separate tubes. We routinely
employ a 250 m inner diameter column in the first dimension
at 2 l/min and switch the valve every 90 s, thus concatena-
tion volumes are only 3 l. The system is fully programmable,
allowing collection not only into multiples of the eight output
channels (A–H) but also into as few as two or as many frac-
tions as there are collection tubes in the device (96 in our
setup). Furthermore, an arbitrary number of samples can be
fractionated, and the rotor valve shifts can be defined by the
user. For example, 12 samples could be scheduled for con-
catenation into eight fractions each in a total of 24 h using 80
min gradients.
When operating in a high pH reversed-phase mode, we use
the first column with a buffer at pH 10, which is devoid of
non-volatile constituents. The column inner diameter and con-
sequently the flow rate are chosen such that the desired
peptide amounts are present in the sample tubes after con-
catenation. For instance, using second dimension columns
with a loading capacity of 2 g, which is typical of the 75 m
inner diameter columns used in many proteomics laborato-
ries, would call for a sample amount of at least 16 g to be
loaded on the first dimension column. Therefore, the first
column should have a capacity of at least the second column
multiplied by the number of desired fractions. In principle, the
entire system can be scaled up or down as required. Within
the constraints mentioned above, different size columns and
separation principles can be combined as long as they are at
least partially orthogonal. For the work reported here, we
standardized on a first dimension column of 250 m inner
FIG. 1. Spider fractionation principle and practical implementation. A, switch mechanism of the rotor valve, illustrating how the flow from
the first dimension separation is divided to eight output lines. B, schematic of the implementation of the spider fractionator. The first dimension
separation is realized as a 250 m inner diameter column, connected upstream through a zero dead volume connector to a nano-HPLC pump
(an ultra high pressure unit is depicted but not required). The zoom-in is a cut-away symbolizing different peptide bands being separated in
the column by different colors. Downstream, the column is connected to the rotor valve from A. The output lines feed into tubes that are filled
in turn, according to the concatenation scheme. The spider-like appearance of the output lines give the name to the device. The arrows indicate
that the output lines can be moved to a new set of tubes for a new separation process. After separation, the tubes are inserted into the
autosampler of an UHPLC for LC-MS/MS analysis of the fractions. C, photo of the prototype spider fractionator used in this work.
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diameter and a length of 30 cm, which is packed with 1.9 m
C18 particles and has an estimated loading capacity of at least
100 g (see “Materials and Methods”).
For the subsequent on-line LC separation, no alterations
compared with standard laboratory procedures are neces-
sary. In the work reported here, the columns were 40 cm long,
75 m inner diameter, and packed with 1.9 m C18 particles.
The 0.1% formic acid in our buffers ensured low pH com-
pared with the first dimension.
The overall fractionation systems was realized by coupling
an EasyLC nanobore HPLC to the first dimension column (see
“Materials and Methods”). Note that back-pressure was only
250 bar. Because no high pressure capability is required, a
wide range of nanoflow pumps used in proteomics would
therefore be suitable. The fractionator principle itself is em-
bodied in an apparatus containing a column oven to maintain
60 °C, the flow-selector valve for fractionation, the required
column, two-dimensional axes for automated multi-collection
plate position selection, a cooling unit to retain fractions at
about 6 °C, a microprocessor control unit for automated con-
tact closure and HPLC interaction, and a driver software to
control, log, and monitor all the parameters (Fig. 1C). The
control unit maintains communications to the upfront HPLC
system, to the rotor valve, and to the downstream fraction
collection system. The collection system is designed to be
fully flexible. Peptides eluting from the column are separated
into packages defined by a time interval by rotor valve shifts.
The shift in valve position directs each package into one of the
eight output lines. Each of these are placed into one of the
eight “rows” (A–H) of a 96-well layout. Output line A elutes into
row A, line B into row B, and so forth. Eight shifts of the rotor
valve will deposit peptides from the column into each tube of
the first column, and the next shift will enter the next output
line and therefore again fill the first row A. In this way, for eight
or less fractions, the output line holder stays at column 1 of
the 12 possible positions of a 96-well plate. In case separation
into more than eight fractions is desired, the output line holder
will move from column 1 to column 2 after eight packages (H1
is followed by A2, supplemental Fig. 1). For 16 fractions, the
output holder will move back to column 1 after eight rotations
(H2 is followed by A1). Likewise, 24, 32, 40, 48, 56, and 96
fractions can be realized. Fractionation into less than eight
fractions or any other desired number between 1 and 96 is
also possible as the rotation valve can be programmed to
direct packages to arbitrary output lines. For instance, in the
case of four fractions, the rotation valve switches directly from
D1 to A1. The collection tubes are maintained cooled and can
be placed in a SpeedVac and subsequently into the auto
sampler of the on-line LC-MS/MS system.
Separation Performance—With the column connected to
the Spider fractionator, we first collected each of 54 fractions
(90 s duration) in their own tubes. Starting from fraction three,
we chose every 8th fraction and analyzed these fractions
separately in 100 min gradients on the 40 cm analytical col-
umn. The 90 s elution windows from the first dimension eluted
roughly in the same region as expected if they had been
separated on a low pH analytical column except that their
elution range was expanded considerably due to the different
pH values (Fig. 2A). However, generally the bulk of the pep-
tides was still concentrated within only about 20–50% of the
total gradient.
Next, we specified an eight fraction concatenation scheme,
meaning that the rotor valve combined the 54 fractions into
eight equally filled gradients. Fractions 3, 11, 19, 27, 35, 43,
and 51, which were measured separately above, were auto-
matically combined by the rotor valve. Analyzing this concat-
enated fraction on the 100 min gradient of the analytical
column resulted in a peptide elution profile that was filled over
the entire range, resembling the super position of the sepa-
rately measured fractions (Fig. 2B). Repeating this experiment
in triplicate yielded essentially identical elution profiles, dem-
onstrating reproducibility of the spider fractionator (supple-
mental Fig. 2).
A desirable feature of a pre-fractionation apparatus is that it
concentrates each individual peptide into as few fractions as
possible. Note that in a two-dimensional separation scheme
there will always be peptides that will be collected into differ-
ent tubes because the fractionation will occur during peak
elution for a certain percentage of them (“peak cutting”).
Furthermore, peptides may or may not be sequenced and
identified in different fractions, depending on the complexity
of the sample and the sequencing speed and sensitivity of the
mass spectrometer. Therefore, it is necessary to quantify
peptide abundance across all fractions. To evaluate the sep-
aration efficiency of the fractionator and pooling scheme, we
therefore employed the “match between runs” option in the
MaxQuant software (11, 38), which allowed the transfer of
identifications between the fractions. Note that the label-free
algorithms in MaxQuant in any case normalize the contribu-
tions of the fractions and add the contributions for peptides
found in more than one (37).
For the majority of peptides (68%), their total intensities
were concentrated in one fraction to more than 75% (Fig. 2C
and supplemental Fig. 3). This is roughly in line with a model
in which the peptide distribution in the analytical dimension is
largely a function of the cutting of peaks in the first dimension.
(In our case, a peak width of 15 s in the first dimension and a
90 s collection window would result in about 15/90  16.6%
of “cut peaks”).
Evaluating the Optimal Number of Fractions—For any sam-
ple, the spider fractionator allows choosing the desired num-
ber of fractions. A large number of fractions will increase
proteome coverage in two ways. First, at any chosen gradient
length, the time available for sequencing peptides will in-
crease with the number of fractions. In complex samples, this
will lead to more identified peptides and proteins. Second, as
there is a maximal loading capacity of the analytic column, a
larger number of total fractions increases the total material
Loss-less Nano-fractionator
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that can be used in a proteomic analysis and therefore its
sensitivity. Conversely, many fractions imply long measure-
ment times per sample and may be less beneficial if sample
size is limited. In practice, a good compromise, maximizing
the effort/gain balance, needs to be found according to the
parameters and the goals of the experiment at hand.
To investigate this, we employed HeLa digest as a typical
complex proteome and determined the number of identified
peptides and proteins as a function of fraction number. We
separated peptides into 4, 8, 16, and 24 fractions. We loaded
20 g of starting material for 4 and 8 fractions, 40 for 16
fractions, and 60 for 24 fractions, so as not to be sample
limited for the individual LC MS/MS runs, in which an esti-
mated 2 g were injected in each case. As expected, sepa-
ration into 24 fractions, followed by 48 h of total MS meas-
urement time, yielded the largest number of different peptides
and proteins groups. In total, 128,966 sequence unique pep-
tides and 10,769 different protein groups were identified by
MaxQuant in the HeLa cells with 1% false discovery rate at
the protein and peptide levels. Match between runs to all files
acquired in this project increased these numbers to 159,024
sequence unique peptides and 11,897 protein groups (sup-
plemental Table 2).
Strikingly, using 16 fractions (32 h measuring time) and 8
fractions (16 h) still resulted in 98 and 95% of those protein
identifications, respectively. Even the four fraction experi-
ments identified 90% of the proteins in 8 h, corresponding to
only 1/6th of the measuring time of the 24 fractions. However,
although the loss of protein identifications was very moderate
with decreasing fraction number, this was not as pronounced
at the peptide level, where only 91, 78, and 62% of peptides
were still found (supplemental Table 2). This observation is
explained by the fact that increasing depth of measurement
will result in a saturating number of identified proteins,
whereas the number of peptides and the sequence coverage
of the proteins still increase. Accordingly, Fig. 3A shows a
rapid rise of identified peptides when accumulating the results
of subsequent fractions within one experiment. The first frac-
tions of each experiment add newly identified peptides at an
almost linear rate. Here, the four-fraction experiment has a
clear advantage as it identifies 28,000 peptides (47,000 with
matching) in the first fraction, whereas the first fraction of
the 24-fraction experiment only results in 19,000 peptides
(32,000 with matching). This reflects the fact that in the
four-fraction experiment each of the fractions contains a
quarter of total peptides, whereas the 24-fraction experi-
FIG. 2. Comparison of pooled and non-pooled peptide mixtures and separation efficiency. A, total ion current of separately collected,
90-s elution cuts from the 1st dimension column. B, total ion current of automatically pooled fractions corresponding to the ones in A. C,
histogram of peptides containing at least 75% of their total mass over all fractions in the indicated number of fractions.
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ment leads a smaller number of indefinable peptides de-
spite the higher amount per peptide. The total number of
peptides identified in the four-fraction experiment is already
matched between 6 and 7 fractions for the 24-fraction ex-
periment, which goes on to yield almost twice the total
number of peptides. At the protein level, the identification
numbers are essentially only a function of the number of
fractions, and that is to say the cumulative number of pro-
teins per fraction are almost identical. The saturation of the
curve has largely occurred by fraction 8, especially when
using match between runs (Fig. 3B).
For the decision of how many fractions the experimenter
should choose, the total number of proteins or peptides as
well as the effort/gain balance need to be considered, as
already mentioned above. For this purpose, we plotted the
total number of proteins and peptides against the peptide-
or protein-to-time ratio (Fig. 3, C and D). Again, it appears
that eight fractions result in an optimum regarding both
factors.
Comparison of the Spider Fractionator to Other High pH
Fractionation Systems—The spider fractionator setup was
compared with a high flow system (150 l/min) coupled to a
2.1 mm  250 mm C18 column and to a recently released
spin column-based high pH reversed-phase peptide fraction-
ation kit (see under “Materials and Methods”).
To analyze potential sample losses, we fractionated 1 g of
peptides from the same HeLa digest on all three systems,
combined the total eluted volume, and compared the median
peptide intensity to a measurement of 1 g of the same
unfractionated peptides. For such low sample amounts, the
high flow and the spin column system resulted in much less
recovered peptides than the spider fractionator (recoveries
were 15, 24, and 81% of the unfractionated sample) (supple-
mental Fig. 4A). Moreover, we fractionated 20 g of the same
HeLa digest with all three systems and compared the median
peptide intensities, numbers of identified peptides, and pro-
tein groups. The spin column setup allowed only fractionation
into eight samples without any concatenation, and for the high
FIG. 3. Effect of different numbers of pooled fractionations on proteome coverage. A, cumulative number of sequence unique peptides
as a function of fraction number for a 4, 8, 16, and 24 fractionation scheme. The upper curves (circles) are obtained with match between runs
enabled in MaxQuant and the lower curves (diamonds) without match between runs. The last fraction of the experiment is labeled in each case.
B, same as A but for protein numbers. C, number of peptides identified per min in 100 min gradient runs as a function of total number of
peptides identified. Values enclosed in the upper ellipse are those employing match between runs and in the lower ellipse without match
between runs. High values on the x and on the y axis are desirable (large number of identifications per min as well as high number of identified
peptides). D, same as C but for protein numbers.
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flow system the samples were concatenated manually. The
spider setup resulted in the highest median peptide intensity,
identified peptides, and protein groups, followed by the high
flow and the spin column system (supplemental Fig. 4, B–F).
The experiments for 1 and 20 g fractionation amounts
point in the direction that the spider fractionator had by far the
lowest sample loss. Major sample losses could have occurred
due to the interaction surfaces in the high flow and the spin
column systems.
Moreover, the fully automated concatenation of the spider
fractionator saved a lot of hands-on time compared with the
two other systems. The major bottlenecks of the high flow
system were losses by handling the high volumes and several
pipetting and concatenation steps as well as the very long
SpeedVac times of up to 6 h for the 12 ml of fractionated
volume.
Spider Fractionator Allows Loss Less Fractionation—Be-
cause of sample losses associated with high flow rate HPLC
systems, fractionation is generally only employed when
large sample amounts are available. However, due to its
operating principle, the spider fractionator should not have
these limitations. To investigate this potential advantage in
detail, we fractionated different amounts of digested HeLa
peptides (0.5, 1, 2, 5, 10, 20, 50, and 100 g) into eight
pooled fractions each. To minimize potential issues associ-
ated with carry-over, we measured the lowest amounts first
and on a new column.
First, we analyzed the behavior at the higher sample
amounts. For the three highest sample loadings and assum-
ing an equal distribution of peptides in all fractions, more than
2 g were available per LC MS/MS run, but only this amount
was injected. This yielded the same number of identified
peptides and proteins (around 11,000 proteins and nearly
110,000 peptides), demonstrating that the spider fractionator
equipped with the 250 m inner diameter column can handle
these amounts of sample or more (Fig. 4, A and B). The
average sequence coverage of the proteome was 26% for
fractionation of more 10 g, decreasing gradually to 20% for
1 g (Fig. 4C).
As expected from the smaller amount of peptide material
injected into the analytical column, the total number of pep-
tides identified decreased from 10 to 1 g of starting material
(maximum of 1.25 to 0.125 g per injection). However, the
loss of identification was much less than linear, decreasing to
about half with 10-fold lower peptide amount. Remarkably,
there was very little loss of protein identifications in the same
range. In particular, when using matching, the 1 g total
loading still resulted in more than 10,000 different protein
groups (7,800 without matching). Loading less than 1 g did
result in a considerable reduction of proteins and peptides.
FIG. 4. Dependence of proteome coverage on
sample amount. A, fractionation of a total of 0. 5, 1, 2,
5, 10, 20, 50, and 100 g of HeLa peptides resulted in
the indicated number of identified peptides. For the
sample amount 1*, we started with 6,600 HeLa cells,
which is equal to 1 g of starting material, for an in-
StageTip digestion with subsequent peptide cleanup
and fractionation. Blue represents peptides identified by
MS/MS and red those identified by match between runs
in MaxQuant. The gray bar indicates that the false dis-
covery rate for match between runs was not validated at
this very low sample amount. In the case of 20, 50, and
100 g of starting material, the volume corresponding to
2 g of peptide material was injected to avoid overload-
ing the analytical column. B, same as A for the number
of identified proteins. C, sequence coverage as a func-
tion of starting peptide material displayed as Tukey
plots. The bold black lines represent the median of all
proteins. The blue box marks the upper and lower quar-
tile of the sequence coverage and the whiskers the
1.5-fold interquartile range. D, median intensity deter-
mined as label-free intensity values by MaxQuant for all
proteins that were quantified in the dilution series are
plotted as a function of initial peptide sample amount.
Each value is the median of all protein quantifications.
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However, 5,724 proteins were still identified by MS/MS from
23,765 peptides even in this case. Note that this may still not
reflect a limitation of the fractionator but instead simply be
due to the nanogram amounts of peptide loaded onto the
analytical column.
To further investigate the apparent absence of sample
losses of the spider fractionator, we next plotted the median
intensities of all individual proteins against the amount of
injected material up to the 20 g value (Fig. 4D). This resulted
in a linear relationship down to the lowest amounts tested,
demonstrating that any potential sample losses incurred by
the spider fractionator, if they occur at all, are so small that
they are not detectable in the setup used here.
To show the applicability of our workflow for a limited
amount of starting material, we prepared peptides directly
from 6,600 HeLa cells (about 1 g (29)) by using the in-
StageTip protocol (3). The complete material of digested and
purified peptides was fractionated using the spider fractiona-
tor resulting in 5,869 protein groups and 37,000 peptides
without and 10,165 protein groups and 72,110 peptides with
matching (Fig. 4, A and B).
In-depth Measurement of Human Cell Lines—Having estab-
lished optimal fractionation parameters and sample require-
ments, we next employed the spider fractionator for the in-
depth measurement of 12 different human cell line proteomes.
Specifically, we used the 8-fraction, 100 min gradient scheme,
resulting in a total measuring time of 16 h, including column
loading and equilibration and the 20 g loading, which was
the minimum amount that saturates the number of identifiable
peptides. Thus, the entire experiment consumed only 8 days
of measurement time and much less than a small cell culture
dish for each cell line (corresponding to about 100,000 HeLa
cells).
Combined with the one replicate HEK293 cell line (see
below), the experiment yielded a total of 199,882 sequence
unique tryptic peptides corresponding to 12,444 different pro-
tein groups (supplemental Table 3). The median sequence
coverage of these protein groups for this cell line dataset was
a remarkable 41.3%. In the 13 cell line experiment the
median number of identified peptides was 87,769, and this
number ranged from 72,471 in the HeLa sample to 105,487
in the GAMG cell line. Applying the match between run
algorithm boosted median peptide identifications by a fur-
ther 47% (Fig. 5A).
The median number of proteins identified in each of the
singlet experiments was 11,472, and this was very consistent
between cell lines (minimum 11,340 in HeLa and maximum
11,634 in GAMG). These are among the deepest proteome
results reported for cell lines so far, which is particularly
remarkable given the small sample consumption and meas-
urement time. The proteome of the 13 cell lines (12,444 pro-
tein groups; 199,882 peptides) mapped to 11,442 protein-
coding genes, which made up more than 57% of the 20,154
entries listened in SwissProt at the time of writing.
The large majority of total identified proteins (78%) was also
identified in each singlet experiment and almost 90% of them
in at least 10 of the 13 experiments (Fig. 5C). This implies that
the proteomes of these different cell lines are quite similar in
terms of expressed and identifiable proteins. It further implies
that our data set, acquired with a data-dependent acquisition
strategy, is substantially complete and can only have a very
small percentage of missing values, despite the use of data
driven shotgun proteomics.
Cell lines, including the ones used here, have often been in
culture for years or decades and even those that are nominally
the same can develop differences over time. Here we had
obtained the human embryonic kidney cell line HEK293 from
two institutes and treated them as separate entities for the
purpose of comparison with different cell lines. Nearly the
same number of proteins as well as peptides was identified
after fractionation in both cases, and the overlap of each of
the fractionated, matched datasets to all identified proteins
was 97.1%, with the unique proteins at the lower levels of
expression in proteome. The Pearson coefficient for the abun-
dance rank order of the proteomes calculated from the scatter
plot in Fig. 5D was 0.96, implying that they were very similar
at the quantitative level as well. Thus, a simple fractionation
experiment establishes that in this case the same cell lines
with different origins are very similar at the proteome level.
We calculated the Pearson correlation between all combi-
nations of the 13 cell lines and plotted the result as a heat map
(Fig. 5E). As expected, the two instances of the HEK293 cells
had the highest correlation, whereas the median correlation
was 0.83. Against this very high median correlation, a few cell
types show a considerably divergent behavior. One of these is
EC, an embryonic carcinoma cell line, whose proteome had a
correlation to other cell lines down to 0.77. This observation
can be readily explained by the fact that EC is the sole
undifferentiated cell line in our set. Interestingly, the only cell
line to which EC has a high correlation is SMC, another outlier
cell line. The proteome of SMC likewise showed a lower overall
correlation to the other cell lines (down to 0.73), and in this case
the biological explanation is that muscle is developmentally
derived from the mesenchyme, whereas the other cell lines are
primarily of epithelial origin. Finally, HepG2 likewise correlates
less well than an average cell type, presumably reflecting the
specialized organismal role of this model of liver function.
To illustrate how readily acquired deep proteomes can shed
light on cellular function, we quantitatively compared SMC
against a cell line whose proteome had typical correlation
values to the other cell lines. For this, we chose LNCaP, a
widely used cell model of prostate cancer. The correaltion
between SMC and LNCaP was comparatively poor (R0.76),
and the scatter plot reveals a large number of proteins that
were expressed at drastically different levels (Fig. 5F). Among
these, we found the epithelial cell adhesion molecule, which is
the classical positive marker used in immunohistochemistry to
stain cells of an epithelial origin, to be strongly increased in
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LNCaP. Conversely, the classical mesenchymal marker vi-
mentin was strongly expressed in SMC. It is known that
vimentin, together with LARP6, stabilizes type I collagen
mRNAs, which in turn leads to up-regulation of the collagens
CO1A1 and CO1A2 (39). Our data show that several other
collagen isoforms are also strongly expressed in this mesen-
chymal cell line, suggesting that they may be up-regulated by
similar mechanisms (Fig. 5F).
DISCUSSION
In the quest for very deep and large scale proteome char-
acterization, pre-fractionation of peptides occupies a pivotal
role. We build upon the success of high pH pre-separation as
a first dimension coupled to concatenated fractionation sam-
ple pooling for the second dimension of analysis. Samples
have been separately collected and then combined in these
approaches, whereas in the spider fractionator introduced
here, concatenation is implemented by a rotating valve. This
valve automatically directs sections of the eluent of the first
column into a number of tubes corresponding to the number
of desired fractions to be analyzed. In this way, any number of
pooled fractions with any concatenation volume can in prin-
ciple be realized. First dimension column diameters and flow
rates are much smaller than those typically used in high
pH-based proteomics workflows, and the absence of inter-
mediate collection points means that there are no obvious
points of sample loss. We implemented the spider fractionator
as an assembly of the first dimension column and its acces-
FIG. 5. Rapid and sensitive sequencing of 13 human
cell line proteomes. A, number of sequences of unique
peptides identified for the different cell lines indicated on
the x axis (see supplemental Table 2 for cell line abbrevia-
tions). Blue indicates the proportion identified by MS/MS
and red the additional peptides identified by match be-
tween runs in MaxQuant. B, same as A for identified protein
numbers. C, pie chart of the proportion of proteins identi-
fied in the indicated number of cell lines. A total of 89% of
the proteins identified are also identified in at least 10 of the
13 cell lines. D, scatter plot of the label-free intensity (LFQ)
assigned by MaxQuant to the same protein in two different
instances of the same HEK293 cell line (termed HEK293 on
the x axis and HEK293* on the y axis, respectively). E, heat
map of the rank order correlation of the 13 different pro-
teomes. The SMC and EC cell lines are outliers with respect
to their correlations to the others and are indicated by
arrows. F, scatter plot of the proteins quantified in both the
LNCaP (epithelial origin) and the SMC cell line (mesenchy-
mal origin). The known epithelial marker epithelial cell ad-
hesion molecule is much more highly expressed in LNCaP,
whereas the known mesenchymal marker vimentin is ex-
tremely highly expressed in SMC. Vimentin together with
LARP6 (colored in green) stabilizes type I collagen mRNA
for CO1A1 and CO1A2 (colored in orange). Several other
collagens (COL12A1, -3A1, -5A1, -6A1, -6A2, -6A3, and
-7A1 colored in yellow) follow the same pattern.
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sories, an automated valve, temperature controls, and an
automatic fraction collection system for unattended multi-
sample fractionation. The device is now routinely used in our
laboratory for any project involving pre-fractionation and has
proven robust in dozens of projects already.
Here, we characterized the spider fractionator in different
dimensions of performance. Comparison of individually com-
bined and pooled samples gave very similar results at high
sample amounts, demonstrating the automated pooling
scheme correctly implements the concatenated high pH strat-
egy. We obtained quantitative intensity profiles over the
pooled fractions for tens of thousands of peptides, which
showed that the bulk of each individual peptide mass is
localized to a single fraction. The fractionator can be operated
in a parameter space defined by the number of fractions and
the width of the volume that is concatenated. Likewise, the
diameter, flow rate, and stationary phase of its column can be
chosen to fit the desired objectives, within at least the range
of up to 100 g, above which a standard high pH setup may
be just as effective. Using the same C18 material as in our
standard LC MS/MS setup, we investigated the influence of
the number of fractions on the depth of proteome coverage.
Four fractions already led to a very good proteome coverage,
and adding additional fractions up to 24 fractions resulted in
asymptotic gain at the protein level, while peptide coverage
still improved. Considering the tradeoffs in measuring time
and available sample quantity in terms of proteins identified
per min, we conclude that an eight-fraction scheme is a good
compromise in many situations.
Using these parameters, we then demonstrated that the
spider fractionator enables extraordinary profiling sensitivity
and depth in high pH fractionation experiments. As little as 1
g of peptide sample, when fractionated, enabled the identi-
fication of more than 10,000 proteins. Analysis of protein
signal as a function of increased loading of the first dimension
column demonstrated that the device has little if any detect-
able sample loss. We then applied the spider fractionator to
the rapid analysis of small amounts of cell line material, a
typical challenge for proteomics. In only 16 h we reached a
proteome coverage of a median of 11,472 different protein
groups (a total of 12,444 different protein goups for all cell
lines). In the past, our group employed much longer meas-
urement times and larger sample amounts and still only
reached smaller total numbers in cell line systems (11, 40). To
our knowledge, these results are also larger than those cur-
rently described in any given cell line system in the literature,
in any case when considering the amount of protein used and
the total measuring time. Furthermore, coverage was ex-
tremely consistent between singlet measurements of different
cell lines, due to the fact that cell lines tend to have qualita-
tively similar proteomes (11, 41) and because the depth of
proteome coverage reached by our workflow makes our
results very robust against ‘missing values’ that can occur in
shotgun proteomics. Although we used a “match between
run” strategy in the experiments described here, which re-
sulted in substantial gains, the identification numbers with-
out matching are also very high. Indeed, because of the near
absence of sample loss, the maximum amount of peptide
material is available for fragmentation and identification. The
increased measuring time due to fractionation implies more
sequencing events, and thus the nano-fractionator is arguably
less reliant on the transfer of peptide identifications.
Various developments can be envisioned to further improve
on the results shown here. For instance, the depth of the
matching library could be increased, which could be used to
reduce the number of fractions without compromising cover-
age. Although not shown here, the spider fractionator would
work equally well with peptide samples that have been de-
rivatized with isotopically labeled mass tags such as iTRAQ or
TMT. In this case, a 10-fold decrease in initial sample amount,
for instance, would directly translate into a 10-fold reduction
in reagent costs. Furthermore, the first dimension column
could be further scaled down to enable even smaller sample
amounts to be efficiently fractionated and ultra-narrow bore
columns and/or ultralow flow rates could also be used in
the on-line dimension. Apart from total proteome measure-
ments, the spider fractionator could also be applied to the
analysis of post-translational modifications, an area where
sensitivity is especially desired. Finally, the scheme pre-
sented here is agnostic in regards to acquisition strategies
(data-dependent acquisition, data-independent acquisition,
or targeted acquisition).
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